Clinical characteristics of COVID-19 patients
During an 18-month period (March 2021 to September 2022), blood samples
were collected from hospitalized COVID-19 patients. A subset of donors
was followed longitudinally at one month (n=44) and up to 6-8 months
(n=25). Our analysis focused on the effect of COVID-19 on various T cell
subsets and B cell immune responses (Graphical abstract). The clinical
and demographic characteristics of the hospitalized COVID-19 cohort are
summarized in Table 1. Our hospitalized COVID-19 cohort represents the
infection in wider society in terms of biological sex distribution,
encompassing 25 males and 19 females, and a mean age of 51.4 years
(Table 1). Table 2 provides the biochemical laboratory parameters for
the participants in the study. The disease categorization for the
patients were moderate or severe as per the guidelines given by the
National Institutes of Health [4].
Table 1-
Demographic and clinical characteristics of the enrolled study
participants